See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2014_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,186,857,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 863,792,000 |
| 2 | PropertyPlantAndEquipmentNet | 201,109,000 |
| 3 | remainder_Assets | 65,938,000 |
| 4 | LiabilitiesCurrent | 582,429,000 |
| 5 | LiabilitiesNoncurrent | 112,973,000 |
| 6 | remainder_Liabilities | 240,215,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 489,720,000 |
| 9 | ResearchAndDevelopmentExpense | 317,093,000 |
| 10 | remainder_Expenses | 484,828,000 |
| 11 | remainder_Revenues | 1,551,346,000 |
| 12 | remainder_NetIncome | -6,810,000 |
| 13 | remainder_ComprehensiveNetIncome | -29,492,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,317,696,000 |
| 1 | Liabilities | 935,617,000 |
| 2 | Expenses | 1,291,641,000 |
| 3 | Revenues | 1,551,346,000 |
| 4 | StockholdersEquity | 2,382,079,000 |
| 5 | NetIncome | 252,895,000 |
| 6 | ComprehensiveNetIncome | 238,149,000 |
| 7 | BaseVar | 3,566,301,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.55 |
| 9 | EconomicCapitalRatio | 3.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
